The urinary concentration of the tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL), a cytokine that induces apoptosis in malignant tumors without affecting healthy cells [39], was increased in patients responding to BCG treatment compared to non-responders [40]. Here, TNFSF10 is linked to cancer.